Compounds > deferoxamine

deferoxamine and oxytetracycline, anhydrous

deferoxamine has been researched along with oxytetracycline, anhydrous in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Barnewall, RE; Ohashi, N; Rikihisa, Y1

Reviews

1 review(s) available for deferoxamine and oxytetracycline, anhydrous

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for deferoxamine and oxytetracycline, anhydrous

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.
    Infection and immunity, 1999, Volume: 67, Issue:5

    Topics: Base Sequence; Cadaverine; Cell Line; Chelating Agents; Deferoxamine; Ehrlichia; Ehrlichia chaffeensis; Ehrlichiosis; Granulocytes; HL-60 Cells; Hot Temperature; Humans; Iron Regulatory Protein 1; Iron-Regulatory Proteins; Iron-Sulfur Proteins; Kinetics; Molecular Sequence Data; Oxytetracycline; Receptors, Transferrin; RNA-Binding Proteins; RNA, Messenger; Up-Regulation; Virulence

1999